한글목차

정맥내 수액요법 세계 시장 규모는 2024년에 25억 1,000만 달러로 평가되었고, 2030년에는 39억 4,000만 달러에 달할 것으로 예상되며, CAGR 7.80%로 성장할 것으로 예측됩니다.

이 성장의 주요 요인은 만성 질환의 이환율 증가, 수술 건수 증가, 세계 정맥 주사제의 승인 건수 증가입니다. IV 치료 클리닉의 확대도 기업의 지리적 존재를 높여 시장에의 침투를 뒷받침하고 있습니다. 또한 정맥 내 치료의 효과와 신속한 대응은 영양 실조 치료 및 특히 경구 섭취가 어려운 환자에게 필요한 영양소를 공급하는 이상적인 솔루션입니다. 인구 고령화로 인해 정맥 영양 지원에 대한 필요성이 높아지면서 시장 확장이 더욱 촉진되고 있습니다. 주목할 만한 사례로는 Sameday Health가 2022년 7월에 출시한 이너 뷰티(Inner Beauty) IV 드립이 있습니다. 이 제품은 피부, 손톱, 모발 건강 개선과 같은 웰빙 및 미용 효과를 강조하며, 예방 및 라이프스타일 헬스케어에 대한 소비자 관심이 증가하고 있음을 보여줍니다.

시장 성장 촉진요인

만성질환과 탈수증상 증가

주요 시장 과제

규제와 안전에 대한 우려

주요 시장 동향

기술 진보 및 서비스 혁신

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 정맥내 수액요법 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율 및 예측
  • 서비스별(면역력 업, 에너지 업, 스킨 케어, 기타)
  • 컴포넌트별(구급 헬스 케어, 일상 헬스 케어)
  • 최종사용자별(병원 및 클리닉, 웰니스 센터 스파, 재택 헬스 케어, 기타)
  • 지역별(북미, 유럽, 아시아태평양, 남미, 중동 및 아프리카)
  • 기업별(2024년)
• 시장 맵
• 서비스별
• 구성 요소별
• 최종 사용자별
• 지역별

제6장 북미의 정맥내 수액요법 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 정맥내 수액요법 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 정맥내 수액요법 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 정맥내 수액요법 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 정맥내 수액요법 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 합병과 인수
• 제품 출시

제13장 세계의 정맥내 수액요법 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• Core IV Therapy, LLC
• Cryojuvenate UK
• B. Braun SE
• Pfizer, Inc.
• JW Life Science
• Amanta Healthcare
• Vifor Pharma Management Ltd
• Otsuka Pharmaceutical Co., Ltd.
• Baxter
• ICU Medical, Inc.

제16장 전략적 제안

제17장 기업 소개와 면책사항

영문목차

The Global IV Hydration Therapy Market was valued at USD 2.51 billion in 2024 and is projected to reach USD 3.94 billion by 2030, growing at a CAGR of 7.80%. This growth is primarily attributed to the increasing incidence of chronic illnesses, rising surgical volumes, and the growing number of intravenous drug approvals worldwide. The expansion of IV therapy clinics is also enhancing companies' geographic presence, thereby boosting market penetration. Additionally, the effectiveness and quick response time of IV therapy make it an ideal solution for treating malnutrition and delivering essential nutrients, especially for patients unable to consume food orally. The aging population, with a heightened need for intravenous nutritional support, is further fueling market expansion. A notable example includes Sameday Health's launch of the Inner Beauty IV drip in July 2022, which emphasizes wellness and aesthetic benefits such as improved skin, nails, and hair health, highlighting the increasing consumer focus on preventive and lifestyle healthcare.

Key Market Drivers

Rising Prevalence of Chronic Diseases and Dehydration-Related Conditions

The growing global burden of chronic illnesses and dehydration-related issues significantly drives the demand for IV hydration therapy. Conditions like diabetes, kidney disease, and digestive disorders often result in fluid imbalances, making intravenous hydration essential for effective treatment. According to the World Health Organization, chronic diseases account for 71% of all global deaths, indicating a broad base of potential IV therapy patients. Dehydration is particularly prevalent among elderly individuals, athletes, and those under stress. The CDC reports that older adults are especially susceptible due to reduced thirst sensitivity and coexisting health conditions, which reinforces the importance of accessible and reliable hydration solutions through IV therapy.

Key Market Challenges

Regulatory and Safety Concerns

IV hydration therapy faces notable regulatory and safety obstacles that could impede market growth. A lack of consistent regulatory frameworks across different regions raises concerns about the quality and professionalism of services offered. In some areas, IV treatments are administered by staff lacking proper medical training, posing risks such as infections, vein inflammation, or electrolyte imbalances. Furthermore, the U.S. FDA has not approved IV hydration therapy for general wellness applications, underlining the need for more comprehensive clinical research to establish safety and efficacy. Addressing these challenges requires the implementation of standardized protocols and oversight to maintain patient safety and public trust.

Key Market Trends

Technological Advancements and Service Innovations

Innovations in technology are reshaping the IV hydration therapy market by making treatments more accessible and patient-centric. Portable infusion systems and integration with telemedicine platforms have enabled home-based treatments, broadening the reach of IV therapy. Additionally, clinics are increasingly offering personalized IV solutions tailored to specific wellness goals, such as immune support, detoxification, and anti-aging. This trend toward customization reflects the rising consumer demand for individualized healthcare experiences, helping drive adoption across various patient segments.

Key Market Players

• Core IV Therapy, LLC
• Cryojuvenate UK
• B. Braun SE
• Pfizer, Inc.
• JW Life Science
• Amanta Healthcare
• Vifor Pharma Management Ltd
• Otsuka Pharmaceutical Co., Ltd.
• Baxter
• ICU Medical, Inc.

Report Scope:

In this report, the Global IV Hydration Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

IV Hydration Therapy Market, By Service:

• Immune Booster
• Energy Booster
• Skin Care
• Others

IV Hydration Therapy Market, By Component:

• Emergency Healthcare
• Routine Healthcare

IV Hydration Therapy Market, By End User:

• Hospitals & Clinics
• Wellness Centers & Spa
• Home Healthcare
• Others

IV Hydration Therapy Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global IV Hydration Therapy Market.

Available Customizations:

Global IV Hydration Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global IV Hydration Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  • 5.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  • 5.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2024)
• 5.3. Market Map
• 5.3.1 By Service
• 5.3.2 By Component
• 5.3.3 By End Users
• 5.3.4 By Region

6. North America IV Hydration Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  • 6.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  • 6.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States IV Hydration Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Service
      • 6.3.1.2.2. By Component
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada IV Hydration Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Service
      • 6.3.2.2.2. By Component
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico IV Hydration Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Service
      • 6.3.3.2.2. By Component
      • 6.3.3.2.3. By End User

7. Europe IV Hydration Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  • 7.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  • 7.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France IV Hydration Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Service
      • 7.3.1.2.2. By Component
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany IV Hydration Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Service
      • 7.3.2.2.2. By Component
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom IV Hydration Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Service
      • 7.3.3.2.2. By Component
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy IV Hydration Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Service
      • 7.3.4.2.2. By Component
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain IV Hydration Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Service
      • 7.3.5.2.2. By Component
      • 7.3.5.2.3. By End User

8. Asia-Pacific IV Hydration Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  • 8.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  • 8.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China IV Hydration Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Service
      • 8.3.1.2.2. By Component
      • 8.3.1.2.3. By End User
  • 8.3.2. India IV Hydration Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Service
      • 8.3.2.2.2. By Component
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan IV Hydration Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Service
      • 8.3.3.2.2. By Component
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea IV Hydration Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Service
      • 8.3.4.2.2. By Component
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia IV Hydration Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Service
      • 8.3.5.2.2. By Component
      • 8.3.5.2.3. By End User

9. South America IV Hydration Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  • 9.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  • 9.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil IV Hydration Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Service
      • 9.3.1.2.2. By Component
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina IV Hydration Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Service
      • 9.3.2.2.2. By Component
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia IV Hydration Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Service
      • 9.3.3.2.2. By Component
      • 9.3.3.2.3. By End User

10. Middle East and Africa IV Hydration Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  • 10.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  • 10.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa IV Hydration Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Service
      • 10.3.1.2.2. By Component
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia IV Hydration Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Service
      • 10.3.2.2.2. By Component
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE IV Hydration Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Service
      • 10.3.3.2.2. By Component
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global IV Hydration Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Core IV Therapy, LLC
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Cryojuvenate UK
• 15.3. B. Braun SE
• 15.4. Pfizer, Inc.
• 15.5. JW Life Science
• 15.6. Amanta Healthcare
• 15.7. Vifor Pharma Management Ltd
• 15.8. Otsuka Pharmaceutical Co., Ltd.
• 15.9. Baxter
• 15.10. ICU Medical, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer